Centre d'information
Articles spécialisés
-
Témoignages de Janssen Immunologie – La vie au-delà du lupus
Shawn, Directeur, Recherche...
En apprendre davantage -
-
-
Participer à une course cycliste pour le myélome multiple
En apprendre davantage -
-
Janssen à la une
Communiqués de presse
Nov 01, 2018
United States
Janssen Shows Commitment to Advancing the Science and Treatment of Blood Cancers and Related Conditions With More Than 80 ASH 2018 Data Presentations From Differentiated Oncology and Cardiovascular Portfolios
Oct 31, 2018
Ireland
Janssen Reports Positive Topline Results for FLAIR Phase 3 Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1
Oct 30, 2018
United States
U.S. FDA Approves INVOKANA® (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Oct 30, 2018
Scotland
Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1
Tweets
Janssen Global
@JanssenGlobal
-
We remain committed to working with the global health community to help overcome the challenges patients with chron… https://t.co/wHplrT5kLv
19 hours 25 min ago
Fermer
Galerie d'art
Nous sommes fiers d'exposer des œuvres d'art créées par des personnes souffrant des pathologies et maladies que nous cherchons à traiter et à prévenir.
Visualiser la galerieMartin Freeman, Not What It's Cracked Up to Be